Evolution of multidrug resistance in Salmonella enterica serovar Typhimurium as a result of biocide exposure.
Evolution of multidrug resistance in Salmonella enterica serovar Typhimurium as a result of biocide exposure.
批准号:
BB/G012016/1
负责人:
Mark Webber
金额:
$55.4万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2009
资助国家:
英国
项目状态:
已结题
起止时间:
2009 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This proposal aims to understand more about how bacteria become resistant to antibiotics and what factors influence the rate at which this can occur. Around the world antibiotic resistance is a major problem, in recent years increasing numbers of bacteria which are Multiply Drug Resistant (MDR) - resistant to three or more classes of antibiotics are being isolated. Bacteria can become resistant to antibiotics in a number of ways, one mechanism they use is known as efflux. Efflux pumps are able to pump antibiotics out of the bacterial cell; they also pump biocides (disinfectants). The use of biocides in farming has increased in recent years as the use of antibiotics as growth promoters in animals has been reduced. Concern has been raised about the potential for biocides to cause antibiotic resistance by selecting for mutant bacteria which produce a greater number of efflux pumps. One route by which people can become infected with pathogenic bacteria is via food, Salmonella are the second most common cause of gastroenteritis in the U.K and the majority of infections are via contaminated food. In recent work the applicants have shown that exposure of Salmonella to various biocides (disinfectants) used on farms can result in selection of mutants which are MDR but are not able to grow as well as their parent. However these experiments used multiple exposures to biocides and it is not clear how many exposures are needed to select MDR, and whether the loss of fitness (ability to grow and infect human cells) is linked to development of MDR. This proposal aims to identify how many biocide exposures are needed to select MDR and whether the fitness cost is linked by performing stepwise exposure experiments and keeping mutants after each exposure. These mutants will then be examined and the antibiotic resistance and fitness measured. These experiments will allow the development of MDR over time to be followed. It is likely that the repeated biocide exposures will select for mutants with multiple mutations within their genomes. Recent development of new sequencing technologies have allowed whole genomes to be sequenced rapidly for relatively little cost. This proposal aims to sequence the genomes of biocide selected mutants to identify mutations involved in biocide-antibiotic cross resistance. The result of these mutations on expression of all the genes of salmonella will be measured as will the ability of mutants to grow in the presence of over 2000 compounds. These results will help assign function to the mutations identified and understand how they affect antibiotic resistance and fitness. The assembly of genome, transcriptome (expression profile of all genes) and phenotype (ability to grow in a range of conditions) is a powerful tool to understand the mechanisms of resistance. The importance of mutations identified in this study will be assessed in two ways. Firstly specific mutations will be re-created in a normal Salmonella strain and the effect on antibiotic resistance and fitness evaluated. Secondly a group of current isolates of MDR Salmonella from animals will be studied for the presence of these mutations in order to identify whether they are found in 'real-world' isolates. The expected outcomes are: An understanding of the mechanisms by which biocides can select antibiotic resistance and an evaluation of whether this is a threat to human health. A better understanding of the fundamental biology of Salmonella. Identification of new target genes for development of novel antibiotics.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Epidemiology of Burkholderia multivorans strains obtained from non-cystic fibrosis patients isolated in large hospitals across the Czech Republic.
从捷克共和国各大医院分离的非囊性纤维化患者中获得的多食伯克霍尔德杆菌菌株的流行病学。
DOI:
10.1016/j.jhin.2013.10.001
发表时间:
2014
期刊:
The Journal of hospital infection
影响因子:
--
作者:
[Hanulik V]
通讯作者:
Hanulik V
Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance.
临床相关的突变体DNA回旋酶改变了超螺旋,改变了转录组,并赋予多药电阻。
DOI:
10.1128/mbio.00273-13
发表时间:
2013-07-23
期刊:
mBio
影响因子:
6.4
作者:
[Webber MA, Ricci V, Whitehead R, Patel M, Fookes M, Ivens A, Piddock LJ]
通讯作者:
Piddock LJ
Antibiotic Resistance Protocols
抗生素耐药性方案
DOI:
10.1007/978-1-4939-7638-6_15
发表时间:
2018
期刊:
影响因子:
--
作者:
[Hu Y]
通讯作者:
Hu Y
Defining mechanisms of antiseptic tolerance against skin microbiota
-
批准号:BB/T014644/1
-
项目类别:Research Grant
-
资助金额:$86.82万
-
财政年份:2020
-
负责人:Mark Webber
-
依托单位:
NATO after Afghanistan
-
批准号:ES/J022063/1
-
项目类别:Research Grant
-
资助金额:$2.28万
-
财政年份:2012
-
负责人:Mark Webber
-
依托单位:
Characterisation of triclosan resistance in Salmonella enterica serovar Typhimurium.
-
批准号:BB/D020476/1
-
项目类别:Fellowship
-
资助金额:$49.7万
-
财政年份:2007
-
负责人:Mark Webber
-
依托单位:
国内基金
海外基金
登录
查看更多内容
地塞米松诱导的人卵巢癌对化疗药物耐受及其机制的研究
-
批准号:81172471
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2011
-
负责人:陈玉霞
-
依托单位:
塞来昔布下调MDR1基因表达的分子机制研究
-
批准号:81000985
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:刘晓蓉
-
依托单位:
MDR1与Anxa2相互作用调节耐药乳腺癌细胞侵袭的分子机制研究
-
批准号:81071731
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:牛瑞芳
-
依托单位:
新型99mTc/188Re肿瘤放射性药物的制备及肿瘤多药耐药基因显像剂的研究
-
批准号:20771018
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2007
-
负责人:张俊波
-
依托单位: